October 2022
Starting from:
£99 + VAT
Format: DOWNLOADABLE PDF
This conference looked at the next steps for cancer care in Scotland, Wales and Northern Ireland - including the development of integrated care across the nations.
Delegates assessed:
- what can be learned and transferred from the experiences of each nation at different stages of integration
- shared issues and opportunities for service delivery improvements going forward
Areas for discussion included how best to support cancer diagnosis, treatment, and care, as well as progress made so far, and the key challenges facing policymakers and health and social care providers in delivering quality care.
It took place against the backdrop of recent policy developments in cancer care plans:
- Scotland - consultation on an updated cancer plan, as well as the cancer strategy for children and young people in Scotland, which looks at opportunities to develop services for younger people
- Wales - the Quality Statement for Cancer from the Welsh Government, which outlines the vision for good quality cancer services
- Northern Ireland - the Cancer Strategy for Northern Ireland 2022-32, which outlines the long-term vision for cancer services
Key areas in the agenda included:
- improving health outcomes - key issues for cancer care across Scotland, Wales and Northern Ireland
- policy - priorities and next steps for cancer care
- recovery from the pandemic - tackling waiting lists - supporting wellbeing - meeting the needs of patients and staff
- the cancer workforce - recruitment and retention - skills development - priorities for funding
- a holistic approach to care - reconfiguring the patient pathway - improving provision and access - tackling health inequalities
- innovation and access - priorities for bringing advances in treatment to patients
- preparing for the future - system transformation - assessing opportunities for research and innovation - next steps for digital care - how to improve sector resilience
We are pleased to have been able to include keynote contributions from Dr Tomas Adell, Director of Hospital Services Reform, Department of Health, Northern Ireland; Pat Vernon, Cancer Lead, Clinical Conditions and Pathways Policy Team, Welsh Government; Anthony Davies, Cancer Lead, Clinical Conditions and Pathways Policy Team, Welsh Government; Sophie Harding, Pharmacogenomics Lead, Royal Pharmaceutical Society; and Professor Deirdre Heenan, Professor of Social Policy, Ulster University.
The conference was an opportunity for stakeholders to consider the issues alongside key policy officials who attended from The Scottish Government - as well as Audit Wales; and the Department of Health, NI.
